Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
Syros Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Syros Pharmaceuticals reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, four executives at Syros Pharmaceuticals received on average a compensation package of $2M, a 15% increase compared to previous year.
Average pay of disclosed executives at Syros Pharmaceuticals
Nancy Simonian, Chief Executive Officer, received $3M in total, which increased by 36% compared to 2017. 71% of Simonian's compensation, or $2.2M, was in option awards. Simonian also received $308K in non-equity incentive plan, $560K in salary, as well as $270 in other compensation.
Joseph J. Ferra, Jr, Chief Financial Officer, received a compensation package of $2.4M. 78% of the compensation package, or $1.9M, was in option awards.
David A. Roth, Chief Medical Officer, earned $1.2M in 2018, a 10% increase compared to previous year.
Eric R. Olson, Chief Scientific Officer, received $1.2M in 2018.
Related executives
You may also like
Source: SEC filing on April 25, 2019.